✦ LIBER ✦

Three distinct regions of allelic loss at 13q14, 13q21-22, and 13q33 in prostate cancer

✍ Scribed by Eija-Riitta Hyytinen; Henry F. Frierson Jr.; James C. Boyd; Leland W.K. Chung; Jin-Tang Dong

Publisher: John Wiley and Sons
Year: 1999
Tongue: English
Weight: 154 KB
Volume: 25
Category: Article
ISSN: 1045-2257
DOI: 10.1002/(sici)1098-2264(199906)25:2<108::aid-gcc6>3.0.co;2-y

No coin nor oath required. For personal study only.

✦ Synopsis

Chromosome 13 is one of the most frequently altered chromosomes in cancer, including carcinoma of the prostate. Two known tumor suppressor genes, RB1 and BRCA2, map to chromosome 13; however, recent reports suggest that unknown genes on 13q are more likely to be involved in the development of prostate cancer. In order more fully to define the genetic changes on chromosome 13 in prostate neoplasms, we analyzed 27 polymorphic microsatellite markers spanning the q arm for loss of heterozygosity in 40 primary tumors and in metastases from 11 other patients who died of prostate cancer. Of the 40 primary tumors, 23 (58%) showed LOH for at least one marker. Three distinct regions at q14, q21-22, and q33, defined by markers D13S267 = D13S153, D13S166 = D13S1225, and D13S259 = D13S274, showed the most frequent LOH, suggesting their involvement in the development of prostate cancer. For the 12 patients whose tumors showed LOH at these markers, the average age at diagnosis was 58 years, which was younger than that (63 years, P Ͻ 0.05) for the 28 patients whose tumors lacked LOH. Ten of the 11 (91%) metastases showed LOH with one or more markers. Two of the three most frequently deleted regions (i.e., q14 and q21-22) in the primary tumors and markers linked to the RB1, BRCA2, and EDNRB genes showed high frequencies (56-71%) of LOH in metastases. These results demonstrate that allelic loss on chromosome 13 at q14, q21-22, and q33 occurs in a subset of primary prostate tumors and is a frequent event in metastatic lesions of prostate cancer.

📜 SIMILAR VOLUMES

Identification of distinct regions of al

Identification of distinct regions of allelic loss on chromosome 13q in nasopharyngeal cancer from paraffin embedded tissues

✍ Apiwat Mutirangura; Navapun Charuruks; Shanop Shuangshoti; Sairoong Sakdikul; Ra 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 79 KB 👁 1 views

Our main purpose was to identify tumor suppressor gene loci on chromosome 13 responsible for nasopharyngeal cancer (NPC) development by analyzing loss of heterozygosity (LOH) and RB protein expression in paraffin embedded tissues. Normal and tumor DNA were extracted from microdissected samples, and

Allelic loss at 1p34, 13q12, 17p13.3, an

Allelic loss at 1p34, 13q12, 17p13.3, and 17q21.1 correlates with poor postoperative prognosis in breast cancer

✍ Mitsuru Emi; Masataka Yoshimoto; Takaaki Sato; Satoshi Matsumoto; Yoshihito Utad 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB

Allelic losses of tumor suppressor genes (TSGs), or the chromosomal regions harboring them, in tumor DNA may become useful postoperative prognostic indicators. To examine whether specific allelic losses might correlate with postoperative survival in a 5-year prospective follow-up, we tested tumors f

Familial 14.5 Mb interstitial deletion 1

Familial 14.5 Mb interstitial deletion 13q21.1–13q21.33: Clinical and array-CGH study of a benign phenotype in a three-generation family

✍ Isabel Filges; Benno Röthlisberger; Christoph Noppen; Nemya Boesch; Friedel Wenz 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB 👁 1 views

Deletion of three distinct regions on ch

Deletion of three distinct regions on chromosome 13q in human non-small-cell lung cancer

✍ Kenji Tamura; Xue Zhang; Yoshinori Murakami; Setsuo Hirohashi; Hong-Ji Xu; Shi-X 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 313 KB 👁 1 views

We examined loss of heterozygosity (LOH) at the retinoblastoma susceptibility gene (RB1) locus on chromosome 13q14 in 20 non-small-cell lung cancers (NSCLCs) using polymorphic markers. The expression of RB protein was examined by immunohistochemical analysis of paraffinembedded specimens of the same

Allelic loss of chromosome 13q14.3 in hu

Allelic loss of chromosome 13q14.3 in human oral cancer: Correlation with lymph node metastasis

✍ Katsunori Ogawara; Akihisa Miyakawa; Masashi Shiiba; Katsuhiro Uzawa; Toshihide 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 212 KB 👁 1 views

To evaluate the role of chromosome 13 deletions in oral squamous cell carcinoma (SCC) progression and to define the precise localization of putative tumor suppressor genes, we studied tumors from 34 unrelated patients with oral SCC by the polymerase chain reaction (PCR)-loss of heterozygosity (LOH)

Loss of heterozygosity and lack of mutat

Loss of heterozygosity and lack of mutations of theXPG/ERCC5 DNA repair gene at 13q33 in prostate cancer

✍ Hyytinen, Eija-Riitta; Frierson, Henry F.; Sipe, Tavis W.; Li, Chang-Ling; Degeo 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 268 KB 👁 2 views

BACKGROUND. Three regions of chromosome 13 were previously identified for having loss of heterozygosity (LOH) in human prostate cancer. One of them, at 13q33, was defined by LOH at markers D13S158 and D13S280. The XPG/ERCC5 gene, a DNA repair gene that when mutated in the germline leads to xeroderma